National Center for Tumor Diseases (NCT) Heidelberg
Katharina Lang is a Clinical Research Nurse at the National Center for Tumor Diseases (NCT) Heidelberg, specializing in Phase 1 oncology studies since September 2020, having previously held the same position at NCT from August 2019 to February 2020. Katharina's experience includes serving as a Hygienefachkraft at SLK-Kliniken Heilbronn GmbH, where responsibilities involved monitoring hygiene standards from March 2020 to August 2020, and extensive clinical experience as a nurse at Universitätsklinikum Heidelberg from 1995 to 2019, with roles across various medical specializations, including hematology and oncology. Educational qualifications encompass a clinical study nurse certificate from KKS Heidelberg (2022 - present), a medical documentation certification from WBS Training AG (2019 - present), advanced oncology and palliative care training, and a nursing degree from the Akademie für Gesundheitsberufe der Universitätsklinik Heidelberg.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.